[1]
|
Liang, A.C., Mandeville, E.T., Maki, T., et al. (2016) Effects of Aging on Neural Stem/Progenitor Cells and Oligodendrocyte Precursor Cells after Focal Cerebral Ischemia in Spontaneously Hypertensive Rats. Cell Transplantation, 25, 705-714. https://doi.org/10.3727/096368916X690557
|
[2]
|
Wang, L., Guo, S., Zhang, N., et al. (2015) The Role of SDF-1/CXCR4 in the Vasculogenesis and Remodeling of Cerebral Arteriovenous Malformation. Therapeutics and Clinical Risk Management, 11, 1337-1344.
https://doi.org/10.2147/TCRM.S87590
|
[3]
|
Cheng, X., Wang, H., Zhang, X., et al. (2017) The Role of SDF-1/CXCR4/CXCR7 in Neuronal Regeneration after Cerebral Ischemia. Frontiers in Neuroscience, 11, 590. https://doi.org/10.3389/fnins.2017.00590
|
[4]
|
Murphy, P.M., Baggiolini, M., Charo, I.F., et al. (2000) International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors. Pharmacological Reviews, 52, 145-176.
|
[5]
|
Balabanian, K., Lagane, B., Infantino, S., et al. (2005) The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes. The Journal of Biological Chemistry, 280, 35760-35766.
https://doi.org/10.1074/jbc.M508234200
|
[6]
|
Rath, D., Chatterjee, M., Meyer, L., et al. (2018) Relative Survival Potential of Platelets Is Associated with Platelet CXCR4/CXCR7 Surface Exposure and Functional Recovery Following STEMI. Atherosclerosis, 278, 269-277.
https://doi.org/10.1016/j.atherosclerosis.2018.10.008
|
[7]
|
Berger, O., Li, G., Han, S.M., et al. (2007) Expression of SDF-1 and CXCR4 during Reorganization of the Postnatal Dentate Gyrus. Developmental Neuroscience, 29, 48-58. https://doi.org/10.1159/000096210
|
[8]
|
Cui, L., Qu, H., Xiao, T., et al. (2013) Stromal Cell-Derived Factor-1 and Its Receptor CXCR4 in Adult Neurogenesis after Cerebral Ischemia. Restorative Neurology and Neuroscience, 31, 239-251. https://doi.org/10.3233/RNN-120271
|
[9]
|
Chu, T., Shields, L., Zhang, Y.P., et al. (2017) CXCL12/CXCR4/CXCR7 Chemokine Axis in the Central Nervous System: Therapeutic Targets for Remyelination in Demyelinating Diseases. Neuroscientist, 23, 627-648.
https://doi.org/10.1177/1073858416685690
|
[10]
|
Schonemeier, B., Kolodziej, A., Schulz, S., et al. (2008) Regional and Cellular Localization of the CXCl12/SDF-1 Chemokine Receptor CXCR7 in the Developing and Adult Rat Brain. The Journal of Comparative Neurology, 510, 207-220. https://doi.org/10.1002/cne.21780
|
[11]
|
Thelen, M. and Thelen, S. (2008) CXCR7, CXCR4 and CXCL12: An Eccentric Trio? Journal of Neuroimmunology, 198, 9-13. https://doi.org/10.1016/j.jneuroim.2008.04.020
|
[12]
|
Williams, J.L., Holman, D.W. and Klein, R.S. (2014) Chemokines in the Balance: Maintenance of Homeostasis and Protection at CNS Barriers. Frontiers in Cellular Neuroscience, 8, 154. https://doi.org/10.3389/fncel.2014.00154
|
[13]
|
Mousavi, A. (2020) CXCL12/CXCR4 Signal Transduction in Diseases and Its Molecular Approaches in Targeted- Therapy. Immunology Letters, 217, 91-115. https://doi.org/10.1016/j.imlet.2019.11.007
|
[14]
|
Ceradini, D.J., Kulkarni, A.R., Callaghan, M.J., et al. (2004) Progenitor Cell Trafficking Is Regulated by Hypoxic Gradients through HIF-1 Induction of SDF-1. Nature Medicine, 10, 858-864. https://doi.org/10.1038/nm1075
|
[15]
|
Wang, Y., Li, G., Stanco, A., et al. (2011) CXCR4 and CXCR7 Have Distinct Functions in Regulating Interneuron Migration. Neuron, 69, 61-76. https://doi.org/10.1016/j.neuron.2010.12.005
|
[16]
|
Daniel, S.K., Seo, Y.D. and Pillarisetty, V.G. (2019) The CXCL12-CXCR4/CXCR7 Axis as a Mechanism of Immune Resistance in Gastrointestinal Malignancies. Seminars in Cancer Biology.
https://doi.org/10.1016/j.semcancer.2019.12.007
|
[17]
|
Puchert, M. and Engele, J. (2014) The Peculiarities of the SDF-1/CXCL12 System: In Some Cells, CXCR4 and CXCR7 Sing Solos, in Others, They Sing Duets. Cell and Tissue Research, 355, 239-253.
https://doi.org/10.1007/s00441-013-1747-y
|
[18]
|
Adlere, I., Caspar, B., Arimont, M., et al. (2019) Modulators of CXCR4 and CXCR7/ACKR3 Function. Molecular Pharmacology, 96, 737-752. https://doi.org/10.1124/mol.119.117663
|
[19]
|
Pujol, F., Kitabgi, P. and Boudin, H. (2005) The Chemokine SDF-1 Differentially Regulates Axonal Elongation and Branching in Hippocampal Neurons. Journal of Cell Science, 118, 1071-1080. https://doi.org/10.1242/jcs.01694
|
[20]
|
Ohshima, Y., Kubo, T., Koyama, R., et al. (2008) Regulation of Axonal Elongation and Pathfinding from the Entorhinal Cortex to the Dentate Gyrus in the Hippocampus by the Chemokine Stromal Cell-Derived Factor 1 Alpha. Journal of Neuroscience, 28, 8344-8353. https://doi.org/10.1523/JNEUROSCI.1670-08.2008
|
[21]
|
Dziembowska, M., Tham, T.N., Lau, P., et al. (2005) A Role for CXCR4 Signaling in Survival and Migration of Neural and Oligodendrocyte Precursors. Glia, 50, 258-269. https://doi.org/10.1002/glia.20170
|
[22]
|
Zhu, C., Yao, W.L., Tan, W., et al. (2017) SDF-1 and CXCR4 Play an Important Role in Adult SVZ Lineage Cell Proliferation and Differentiation. Brain Research, 1657, 223-231. https://doi.org/10.1016/j.brainres.2016.06.011
|
[23]
|
Krathwohl, M.D. and Kaiser, J.L. (2004) Chemokines Promote Quiescence and Survival of Human Neural Progenitor Cells. Stem Cells, 22, 109-118. https://doi.org/10.1634/stemcells.22-1-109
|
[24]
|
Peng, H., Kolb, R., Kennedy, J.E., et al. (2007) Differential Expression of CXCL12 and CXCR4 during Human Fetal Neural Progenitor Cell Differentiation. Journal of Neuroimmune Pharmacology, 2, 251-258.
https://doi.org/10.1007/s11481-007-9081-3
|
[25]
|
Lounsbury, N. (2020) Advances in CXCR7 Modulators. Pharmaceuticals (Basel), 13, 33.
https://doi.org/10.3390/ph13020033
|
[26]
|
Wang, C., Chen, W. and Shen, J. (2018) CXCR7 Targeting and Its Major Disease Relevance. Frontiers in Pharmacology, 9, 641. https://doi.org/10.3389/fphar.2018.00641
|
[27]
|
Zhu, Y. and Murakami, F. (2012) Chemokine CXCL12 and Its Receptors in the Developing Central Nervous System: Emerging Themes and Future Perspectives. Developmental Neurobiology, 72, 1349-1362.
https://doi.org/10.1002/dneu.22041
|
[28]
|
Liu, S., Jia, X., Li, C., et al. (2013) CXCR7 Silencing Attenuates Cell Adaptive Response to Stromal Cell Derived Factor 1 Alpha after Hypoxia. PLoS ONE, 8, e55290. https://doi.org/10.1371/journal.pone.0055290
|
[29]
|
Sanchez-Alcaniz, J.A., Haege, S., Mueller, W., et al. (2011) CXCR7 Controls Neuronal Migration by Regulating Chemokine Responsiveness. Neuron, 69, 77-90. https://doi.org/10.1016/j.neuron.2010.12.006
|
[30]
|
Rajagopal, S., Kim, J., Ahn, S., et al. (2010) Beta-Arrestin But Not G Protein-Mediated Signaling by the “Decoy” Receptor CXCR7. Proceedings of the National Academy of Sciences of the United States of America, 107, 628-632.
https://doi.org/10.1073/pnas.0912852107
|
[31]
|
Uto-Konomi, A., Mckibben, B., Wirtz, J., et al. (2013) CXCR7 Agonists Inhibit the Function of CXCL12 by Down- Regulation of CXCR4. Biochemical and Biophysical Research Communications, 431, 772-776.
https://doi.org/10.1016/j.bbrc.2013.01.032
|
[32]
|
Chen, Q., Zhang, M., Li, Y., et al. (2015) CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4. Stem Cells, 33, 2574-2585. https://doi.org/10.1002/stem.2022
|
[33]
|
Wei, S.T., Huang, Y.C., Hsieh, M.L., et al. (2020) Atypical Chemokine Receptor ACKR3/CXCR7 Controls Postnatal Vasculogenesis and Arterial Specification by Mesenchymal Stem Cells via Notch Signaling. Cell Death and Disease, 11, 307. https://doi.org/10.1038/s41419-020-2512-2
|